PubMed دسترسی آزاد

Can continuous glucose monitoring-derived glycemic variability predict retinal neurodegeneration earlier than HbA1c in patients without clinically apparent retinopathy?

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

Early screening for diabetic retinopathy (DR) has long relied on the detection of fundus vascular lesions. However, accumulating evidence indicates that retinal neurodegeneration may occur before overt microvascular abnormalities become clinically visible. At the stage of no clinically apparent diabetic retinopathy (NDR), glycated hemoglobin A1c (HbA1c), by virtue of its averaging nature, is unable to adequately reflect the acute metabolic stress imposed by short-term glycemic variability (GV) on the retinal neurovascular unit (NVU). The increasing use of continuous glucose monitoring (CGM) has made dynamic glycemic metrics such as time in range (TIR) and coefficient of variation (CV) clinically accessible. This review summarizes the clinical and mechanistic evidence supporting CGM-derived GV metrics in the association with early retinal injury in patients with NDR. Mechanistic studies indicate that fluctuating hyperglycemia induces mitochondrial oxidative stress more readily than sustained hyperglycemia and can activate Müller cell- and microglia-mediated neuroinflammation while disrupting tight junctions within the blood-retinal barrier. Clinical studies further show that reduced TIR and elevated CV are associated with early thinning of the retinal nerve fiber layer and reduced microvascular density, and some of these associations remain significant after adjustment for HbA1c. On this basis, we propose a dual-dimensional risk assessment strategy combining HbA1c with TIR/CV and suggest that patients with NDR who exhibit marked glycemic variability on CGM should undergo intensified monitoring. Integrating dynamic CGM metrics with optical coherence tomography (OCT) and OCT angiography (OCTA) may enable risk stratification during the NDR stage and shift the intervention window for DR forward to a critical phase for neuroprotection.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل

کلیدواژه‌ها

continuous glucose monitoringdiabetic retinopathyearly warningglycated hemoglobinglycemic variabilityretinal neurodegenerationtime in range
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Glycaemic Variability and C-Peptide in Bangladeshi Children, Adolescents, and Young Adults With Diabetes: A Prospective Study.

OBJECTIVES: To characterise the magnitude of glycaemic variability and to examine the factors associated with it, with particular attention to residual beta-cell function measured by fasting C-peptide, in children, adolescents, and young adults with diabetes in Bangladesh. DESIGN AND SETTING: Prospective observational study at the BADAS Paediatric Diabetes Care and Research Centre, BIRDEM, Dhaka, using 14 days of blinded professional c…

PubMed2026

Comparative analysis of postprandial changes in the lipidome of capillary plasma and dry blood spots of young women.

PURPOSE: The postprandial period provides a dynamic window to assess metabolic function, as nutrient intake elicits measurable shifts in metabolism, that can be used to assess health status. Traditional venipuncture, though standard for blood sampling, poses practical limitations for postprandial studies that require repeated collections. This study evaluated the feasibility of using dry blood spots (DBS) as a minimally invasive altern…

PubMed2026

A Comprehensive Dual Platform, End-to-end Workflow for Metabolic Profiling of Dried Blood Microsamples.

Blood microsampling (BµS) has emerged as a robust, minimally invasive alternative to traditional venipuncture, enabling the collection of low-volume specimens outside conventional clinical settings. By supporting decentralized sampling and improving patient adherence, these devices can be integrated with advanced omics technologies to facilitate large-scale and longitudinal study designs. However, successful implementation requires opt…

PubMed2026

Effects of ultra-processed food reduction intervention on postprandial glucose and glycaemic variability in Korean young adults: study protocol for the ULTRA-CGM randomised controlled trial.

INTRODUCTION: High intake of ultra-processed foods (UPFs) is associated with an increased risk of type 2 diabetes. However, evidence from randomised controlled trials evaluating the effect of UPF reduction on postprandial glucose responses and glycaemic variability in young adults is limited. The Ultra-Processed Food Reduction Intervention and Continuous Glucose Monitoring (ULTRA-CGM) trial aims to evaluate the effects of a UPF-reducin…